CompoAtlas

Regularity

Regularity, licence 80105007: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Vitazan Herbs and Vitamins Inc
NPN or DIN-HM
80105007
Status
Active licence
Licence date
8 October 2020
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Juglans cinerea

Source : Ecorce (tronc)

33.0 mgNot calculated
Juglans nigra

Source : Enveloppe

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 24 mg

6.0 mgNot calculated
Rumex crispus

Source : Racine

18.0 mgNot calculated
Syzygium aromaticum18.0 mgNot calculated
Zea mays

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 116 mg

29.0 mgNot calculated
Cnicus benedictus

Source : Sommité

18.0 mgNot calculated
Plantago ovata

Source : Enveloppe

305.0 mgNot calculated
Allium sativum

Source : Bulbe

3.0 mgNot calculated
Plantago major

Source : Feuille

23.0 mgNot calculated

Non-medicinal ingredients

Dioxyde de silicium, Caprylate de magnésium, Stéarate de magnésium, Hypromellose, Caprylate de calcium, Extrait de graine de Pamplemousse, Eau purifiée, Bentonite

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19.0 Année(s)5.0 Capsule2.0 Tous les jours

Uses authorised in Canada

Psyllium promotes bowel movements by increasing bulk volume and water content. Psyllium provides gentle relief of constipation and/or irregularity.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80105007

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line